Veracyte Inc (VCYT)
Healthcare
Diagnostics & Research
44.90 $
-3.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Veracyte Inc (VCYT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,486 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,125 | 1,115 | 1,200 | 1,234 | 1,275 | 1,300 | 1,315 | 1,344 | 1,368 | 1,406 | 1,436 | 1,486 | |
| 271 | 286 | 290 | 321 | 357 | 372 | 383 | 415 | 449 | 488 | 522 | 575 | |
| 202 | 216 | 209 | 236 | 274 | 239 | 186 | 219 | 316 | 363 | 263 | 300 | |
| 202 | 216 | 209 | 236 | 274 | 289 | 287 | 321 | 366 | 413 | 439 | 485 | |
| 39 | 40 | 47 | 50 | 49 | 47 | 54 | 51 | 48 | 45 | 50 | 54 | |
| 16 | 16 | 18 | 19 | 20 | 22 | 24 | 25 | 20 | 21 | 21 | – | |
| 693 | 703 | 754 | 752 | 762 | 746 | 754 | 773 | 767 | 767 | 767 | 767 | |
| 124 | 89 | 116 | 113 | 109 | 102 | 99 | 96 | 92 | 89 | 86 | 83 | |
| 71 | 71 | 81 | 102 | 99 | 124 | 120 | 123 | 110 | 96 | 92 | 98 | |
| 57 | 61 | 58 | 72 | 70 | 79 | 75 | 76 | 72 | 60 | 56 | 63 | |
| 5.0 | 5.1 | 6.0 | 7.2 | 7.3 | 7.5 | 7.4 | 6.4 | 4.3 | 4.1 | 4.3 | 5.8 | |
| 13 | 13 | 12 | 12 | 9.7 | 8.6 | 16 | 11 | 5.5 | 4.6 | 6.9 | 8.0 | |
| 1,054 | 1,044 | 1,119 | 1,133 | 1,176 | 1,176 | 1,195 | 1,221 | 1,258 | 1,310 | 1,344 | 1,388 | |
| -440 | -468 | -470 | -464 | -449 | -444 | -437 | -438 | -419 | -378 | -349 | -323 | |
| 73 | 73 | 75 | 77 | 78 | 80 | 80 | 80 | 80 | 81 | 81 | 82 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.